Open AccessFluoxetine Affects Intestinal Motility via 5-HT3 and Muscarinic Receptors in ex vivo Mouse Model
Author(s) -
Pissared Khuituan,
Chotika Nhaemchei,
Sakda Pradab,
Sakena K-da,
Nipaporn Konthapakdee
Publication year - 2021
Publication title -
sains malaysiana
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.251
H-Index - 29
eISSN - 2735-0118
pISSN - 0126-6039
DOI - 10.17576/jsm-2021-5012-15
Subject(s) - fluoxetine , serotonin , muscarinic acetylcholine receptor , endocrinology , medicine , atropine , chemistry , motility , serotonin reuptake inhibitor , pharmacology , 5 ht receptor , receptor , biology , genetics
Fluoxetine, a selective serotonin reuptake inhibitor anti-depressant, causes undesirable side effects, including diarrhea and constipation. This research investigated the direct effects of fluoxetine at 0.001, 0.01, 0.1, 1, 10, and 100 µM on duodenal and proximal colonic tissue contractions. The investigation aimed to determine related mechanisms using an isolated mouse intestine model. Our study showed that fluoxetine at 0.001 μM increased the amplitude of contraction in colonic tissue but decreased the amplitude in duodenal tissue. The direct application of higher concentrations of fluoxetine (1, 10, and 100 µM) reduced the amplitude of contractions in proximal colonic tissue. Moreover, we found that the stimulatory effect of 0.001 µM fluoxetine on the tone of contractions could be prevented by pre-incubating the tissue in ondansetron and atropine. Our findings suggest that the inhibition of the effect of fluoxetine was mainly mediated via 5-HT3 receptors and muscarinic signaling. These findings might explain the conflicting gastrointestinal symptoms caused by fluoxetine.